# Quillivant XR

NDC: 24478-321
Generic name: methylphenidate hydrochloride
Labeler / Manufacturer: NextWave Pharmaceuticals, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20121001

FDA application: NDA202100

## Active ingredients

- METHYLPHENIDATE HYDROCHLORIDE: 300 mg/60mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24478-321"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24478-321
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c2dc2109-44a6-4797-b04e-18761dd9d45a